KELLY DAVIS: Open Payments
NPI 1609994151 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 16 payments from 11 companies in 2025. Trend: 2023 $663 · 2024 $397 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 1 | $106 |
| Daiichi Sankyo Inc. | 4 | $76 |
| Organon LLC | 3 | $48 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Astellas Pharma US Inc | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| MILLICENT US INC | 1 | $19 |
| Hologic Sales and Service, LLC | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: KEVEYIS, INJECTAFER, NEXPLANON, ACCRUFER, Veozah, Lynkuet, FEMRING, MYOSURE TISSUE REMOVAL DEVICE.
Industry payments across VA — which companies pay providers there.
